You are here

oncology

BioNTech predicts return to revenue growth in 2025

Reuters

Tue, 01/9/24 - 09:44 am

Roche Signs Potential $1B ADC Cancer Deal with China’s MediLink

BioSpace

Wed, 01/3/24 - 09:36 am

MediLink Therapeutics

antibody-drug conjugate

Oncology drugmakers seek the sweet spot between efficacy and tolerability

Pharma Voice

Mon, 12/11/23 - 10:16 am

drug development

FDA renews Syapse collaboration to use real-world data in oncology

Clinical Trials Arena

Wed, 12/6/23 - 08:53 pm

real world data

‘Kid-first’ startup BrainChild wants to shift the paradigm on pediatric cancer drugs

Fierce Biotech

Tue, 12/5/23 - 09:46 am

pediatric cancer

clinical trials

Gilead Oncology’s brand refresh takes back the possibilities cancer steals

Medical Marketing and Media

Mon, 11/20/23 - 09:36 pm

Gilead Oncology

Alkermes Spins Off Oncology Business with $275M to Focus on Neuroscience

BioSpace

Wed, 11/15/23 - 11:58 am

FDA's oncology office uses advisory committee to spotlight timely accelerated approval confirmation

Fierce Pharma

Wed, 11/15/23 - 11:20 am

accelerated approvals

Acrotech Biopharma

Bayer adds a new life science incubator in China

Pharmaphorum

Tue, 11/7/23 - 10:04 am

Moderna, Caris Life Team Up to Advance mRNA-Based Oncology Therapeutics

Marketwatch

Wed, 10/25/23 - 09:55 am

Moderna Therapeutics

Caris Life Sciences

ESMO: AstraZeneca aims for ‘2.0’ cancer pipeline, shares bispecific data

Fierce Biotech

Tue, 10/24/23 - 07:52 pm

Merck discontinues some cancer drug development with China's Sichuan Kelun

Reuters

Tue, 10/24/23 - 10:00 am

Sichuan Kelun Pharmaceutical

Charles River offers clients new database for pediatric oncology research

Biopharma Reporter

Tue, 10/24/23 - 09:40 am

Charles River Labs

ESMO: Rain in Spain doesn’t dampen spirits of 33,000 oncologists

Fierce Pharma

Mon, 10/23/23 - 09:17 am

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

CP Wire/Businesswire

Sun, 10/8/23 - 06:16 pm

Bristol Myers Squibb

Mirati Therapeutics

Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics

Tue, 10/10/23 - 05:29 pm

Bristol Myers Squibb

Mirati Therapeutics

Lilly Deepens Oncology Pipeline with $1.4B Point Biopharma Purchase

BioSpace

Tue, 10/3/23 - 11:59 am

Point Biopharma

Amgen unveils Partners of Choice oncology network

Medical Marketing and Media

Thu, 09/21/23 - 06:35 pm

White House announces plan to tackle cancer drug supply issues

10news.com

Wed, 09/13/23 - 06:14 pm

Immuneering takes aim at cancer’s ‘superhighway’

Pharma Voice

Mon, 09/11/23 - 06:50 pm

Pages